Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Mantel-Teeuwisse, Aukje K"'
Autor:
Etukakpan, Alison, Uzman, Nilhan, Ozer, Ozge, Tofade, Toyin, Nair Leite, Silvana, Joda, Arinola, Choonara, Yahya, Mwila, Chiluba, Azzopardi, Lilian M., Mantel-Teeuwisse, Aukje K., Rahal, Mohammad, Darwish, Rula, Lee, Beom-Jin, Shakya, Rajani, Gallagher, Paul J., Moreau, Pierre, Lourenço, Luis, McKinnon, Ross A., Altiere, Ralph J.
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy. 9:100234
Background: A needs-based approach is desirable for the transformation of pharmaceutical education, and to link pharmaceutical education with the health needs of populations and national priorities. There are varying levels of data in the literature
Autor:
Bloem, Lourens T, Bot, Rosalinde E, Mantel-Teeuwisse, Aukje K, van der Elst, Menno E, Sonke, Gabe S, Klungel, Olaf H, Leufkens, Hubert G M, Hoekman, Jarno
Aims: Cancer drugs are increasingly approved through expedited regulatory pathways including the European conditional marketing authorization (CMA). Whether, when taking CMA post-approval confirmatory trials into account, the level of evidence and cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______101::e5c959bcaf061d2f1111d91f7dad98fa
https://dspace.library.uu.nl/handle/1874/425060
https://dspace.library.uu.nl/handle/1874/425060
Autor:
Leufkens, Hubert G, Kusynová, Zuzana, Aitken, Murray, Hoekman, Jarno, Stolk, Pieter, Klein, Kevin, Mantel-Teeuwisse, Aukje K, Afd Pharmacoepi & Clinical Pharmacology, Innovation and Sustainability, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Drug Discovery Today, 27(8), 2252. Elsevier Ltd
The future of medicines is likely determined by an array of scientific, socioeconomic, policy, medical need, and geopolitical factors, with many uncertainties ahead. Here, we report from a scenario project, analyzing various trends, crucial and compl
Autor:
Bloem, Lourens T, Bot, Rosalinde E, Mantel-Teeuwisse, Aukje K, van der Elst, Menno E, Sonke, Gabe S, Klungel, Olaf H, Leufkens, Hubert G M, Hoekman, Jarno, Afd Pharmacoepi & Clinical Pharmacology, Dep Farmaceutische wetenschappen, Innovation and Sustainability, Pharmacoepidemiology and Clinical Pharmacology, Innovation Studies
Publikováno v:
British Journal of Clinical Pharmacology, 88(5), 2169. NLM (Medline)
Aims: Cancer drugs are increasingly approved through expedited regulatory pathways including the European conditional marketing authorization (CMA). Whether, when taking CMA post-approval confirmatory trials into account, the level of evidence and cl
Autor:
Vreman, Rick A, Geenen, Joost W, Knies, Saskia, Mantel-Teeuwisse, Aukje K, Leufkens, Hubert G M, Goettsch, Wim G, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
PharmacoEconomics, 39(10). Adis International Ltd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::5246c44c17397a3bb6ad078f43e3cd2f
https://dspace.library.uu.nl/handle/1874/413013
https://dspace.library.uu.nl/handle/1874/413013
Autor:
Bloem, Lourens T., Vreman, Rick A., Peeters, Niels W.L., Hoekman, Jarno, van der Elst, Menno E., Leufkens, Hubert G.M., Klungel, Olaf H., Goettsch, Wim G., Mantel-Teeuwisse, Aukje K., Afd Pharmacoepi & Clinical Pharmacology, Innovation and Sustainability, Innovation Studies, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Bloem, L T, Vreman, R A, Peeters, N W L, Hoekman, J, van der Elst, M E, Leufkens, H G M, Klungel, O H, Goettsch, W G & Mantel-Teeuwisse, A K 2021, ' Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies ', Clinical and Translational Science, vol. 14, no. 4, pp. 1566-1577 . https://doi.org/10.1111/cts.13027
Clinical and Translational Science
Clinical and Translational Science, 14(4), 1566. Wiley-Blackwell Publishing Ltd
Clinical and Translational Science, Vol 14, Iss 4, Pp 1566-1577 (2021)
Clinical and Translational Science
Clinical and Translational Science, 14(4), 1566. Wiley-Blackwell Publishing Ltd
Clinical and Translational Science, Vol 14, Iss 4, Pp 1566-1577 (2021)
We aimed to determine whether uncertainties identified by the European Medicines Agency (EMA) were associated with negative relative effectiveness assessments (REAs) and negative overall reimbursement recommendations by national health technology ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a71acd97b023da84d700690233e35581
https://dspace.library.uu.nl/handle/1874/412025
https://dspace.library.uu.nl/handle/1874/412025
Autor:
Dankers, Marloes, Nelissen-Vrancken, Marjorie H.J.M.G., Hart, Bertien H., Lambooij, Anke C., van Dijk, Liset, Mantel-Teeuwisse, Aukje K., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Pharmacology Research and Perspectives, 9(3):e00750. Wiley
Pharmacology Research & Perspectives
Pharmacology Research & Perspectives, Vol 9, Iss 3, Pp n/a-n/a (2021)
Pharmacology Research and Perspectives, 9(3), 1. Wiley-Blackwell Publishing Ltd
Pharmacology Research & Perspectives
Pharmacology Research & Perspectives, Vol 9, Iss 3, Pp n/a-n/a (2021)
Pharmacology Research and Perspectives, 9(3), 1. Wiley-Blackwell Publishing Ltd
To evaluate the clinical benefit of new medicines for type 2 diabetes mellitus (T2DM), the Dutch guideline committee T2DM in primary care established the importance of outcomes and minimal clinically important differences (MCIDs). The present study u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf4aa4f0b973fe25158ac584a0cf7fa8
https://research.rug.nl/en/publications/143c9f77-4824-495e-bf8f-b208477a8914
https://research.rug.nl/en/publications/143c9f77-4824-495e-bf8f-b208477a8914
Autor:
Mantel-Teeuwisse, Aukje K., Meilianti, Sherly, Khatri, Bidhata, Yi, Whitley, Azzopardi, Lilian M., Gómez, Jaime Acosta, Gülpınar, Gizem, Bennara, Karima, Uzman, Nilhan, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Education Sciences, 11(6), 1. MDPI
Education Sciences, Vol 11, Iss 296, p 296 (2021)
Education Sciences, Vol 11, Iss 296, p 296 (2021)
To ensure the sustainability of pharmacy practice and provide health for all, pharmacy as a profession must embrace the digital transformation that has been changing healthcare at a rapid pace. The International Pharmaceutical Federation (FIP) has co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8322a2807e1126dc827d78b4d39bd845
https://avesis.gazi.edu.tr/publication/details/52b97911-ccc0-4856-ad07-c8f64a060611/oai
https://avesis.gazi.edu.tr/publication/details/52b97911-ccc0-4856-ad07-c8f64a060611/oai
Autor:
Vreman, Rick A., Naci, Huseyin, Goettsch, Wim G., Mantel-Teeuwisse, Aukje K., Schneeweiss, Sebastian G., Leufkens, Hubert G.M., Kesselheim, Aaron S., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Clinical Pharmacology and Therapeutics, 108(2), 350. Nature Publishing Group
Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics
Assessments of clinical evidence vary between regulators and health technology assessment bodies, but precise differences remain unclear. To compare uncertainties raised on the clinical evidence of approved drugs, we analyzed assessments of regulator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e0959d8e7732568b39ed85e54a6beac
http://eprints.lse.ac.uk/104271/
http://eprints.lse.ac.uk/104271/